{"disease":{"id":"primary-cns-lymphoma-pcnsl","name":"primary cns lymphoma pcnsl"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06737250","title":"NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"NOBO Medicine","has_results":false},{"nct_id":"NCT05274139","title":"Treatment of Primary CNS Lymphoma ( FTD )","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Mingzhi Zhang","has_results":false},{"nct_id":"NCT07062627","title":"Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Hyungwoo Cho","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}